ORCA Therapeutics B.V. is a privately-funded biopharmaceutical company designing and developing new oncolytic immunotherapies for treatment of cancer using Oncolytic Replication Competent Agents (ORCA).
At ORCA we are passionate about using viruses to cure cancer patients. Our proprietary technologies allow us to engineer powerful oncolytic adenoviruses that selectively kill cancer cells and induce an antitumor immune response.
ORCA’s lead compound ORCA-010 is being developed for treatment naive patients with prostate cancer.
For more information, please visit http://www.orca-therapeutics.com
Company Details
- Employees
- 6
- Founded
- -
- Address
- Jonkerbosplein 52, Nijmegen,6534 Ab,netherlands
- Phone
- +31 02 0444 1826
- Industry
- Biotechnology
- Website
- orca-therapeutics.com
- HQ
- Nijmegen
Orca Therapeutics Questions
Orca Therapeutics's helpline number is +31 02 0444 1826
Orca Therapeutics's website is orca-therapeutics.com
Orca Therapeutics's LinkedIn profile is https://nl.linkedin.com/company/orca-therapeutics
Orca Therapeutics has
6 employees.
View email and phone details for 6
employees at Orca Therapeutics.
Orca Therapeutics's industry is
Biotechnology
Orca Therapeutics's top competitors are
Northsea Therapeutics,
Isa Pharmaceuticals,
Vectory,
Leyden Labs,
Cimcure B.v.,
Scenic Biotech,
Lava Therapeutics N.v.,
Uniqure,
Lumicks,
Agendia.
Orca Therapeutics's categories are Biotechnology
Orca Therapeutics's founding year is 2005
